parlazin potahovaná tableta 10mg - rezultati iskanja

Evropska unija - danščina - EMA (European Medicines Agency)

duoresp spiromax

teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - medicin for obstruktiv sygdomme, - asthma duoresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdduoresp spiromax is indicated in adults, aged 18 years and older for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).

Evropska unija - danščina - EMA (European Medicines Agency)

jylamvo

therakind (europe) limited - methotrexat - arthritis, psoriatic; precursor cell lymphoblastic leukemia-lymphoma; psoriasis; arthritis, rheumatoid; arthritis - antineoplastiske midler - i rheumatological og dermatologiske diseasesactive reumatoid artritis hos voksne patienter. polyarthritic former for aktiv, svær juvenil idiopatisk artritis (jia) i unge og børn i alderen 3 år og derover, når svar på non-steroide anti-inflammatoriske lægemidler (nsaid) har været utilstrækkelig. alvorlige, behandling-ildfaste invaliderende psoriasis, som ikke reagerer tilstrækkeligt til, at andre former for behandling, som lysbehandling, psoralen og ultraviolette stråler (puva) terapi og retinoider, og svær psoriasis arthritis hos voksne patienter. i oncologymaintenance behandling af akut lymfoblastær leukæmi (all) hos voksne, unge og børn i alderen 3 år og derover.

Evropska unija - danščina - EMA (European Medicines Agency)

trimbow

chiesi farmaceutici s.p.a. - beclometasone dipropionate, formoterol fumarate dihydrat, glycopyrronium bromid - pulmonal sygdom, kronisk obstruktiv - medicin for obstruktiv sygdomme, - maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and high dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year. copdmaintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5. asthmamaintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.